RedUSe (Reducing Use of Sedatives)
Multi-strategy programme in residential aged care: sedative audit and feedback, staff education by consultant pharmacists, and interdisciplinary sedative reviews.
- Years
- 2014–2016
- Country
- Australia
- Topic
- Low value carePatient safetySleep
- Asks people to
- Stop
- Strategy
- Audit feedback
- Channel
- Clinical setting
- Audience
- CliniciansOlder adultsaged-care staff, GPs, pharmacists
Evidence
ObservationalPositive
150 facilities, 12,157 residents: regular benzodiazepine use fell from 22.2% to 17.6% and antipsychotics 13%, with no substitution.
Sponsor (who paid)
- University of Tasmania (Westbury et al.) Academic
Credits (who made it)
Not recorded yet.
Sources
- RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities evaluation · 2018 · DOI 10.5694/mja17.00857 · PMID 29747564
Research notes
Created 2026-10-23 from the sleep campaign literature search (PubMed and web search; OpenAlex was unreachable), see docs/sleep-campaigns-literature.md. Findings are paraphrased from abstracts, not full texts; official URLs come from search results and were not opened. University affiliation from general knowledge of the RedUSe programme, not checked against the record.
Record cases/au-reduse.json, updated 2026-10-23· Link to this campaign